ストックスクリーナーアプリを入手
235.46
1.89%
4.37
アフターアワーズ：
235.46
前日終値:
$231.09
開ける：
$234.58
24時間の取引高:
766.38K
Relative Volume:
0.84
時価総額：
$16.96B
収益：
$3.07B
当期純損益:
$493.70M
株価収益率:
34.66
EPS:
6.7935
ネットキャッシュフロー:
$468.90M
1週間 パフォーマンス:
-4.23%
1か月 パフォーマンス:
-6.00%
6か月 パフォーマンス:
-7.12%
1年 パフォーマンス:
+5.24%
1日の値動き範囲:
$231.43
$237.20
1週間の範囲:
$228.40
$249.16
52週間の値動き範囲:
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
235.46 | 16.96B | 3.07B | 493.70M | 468.90M | 6.7935 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 167.68B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.33B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 37.69B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.65B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.63B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 開始されました | Barclays | Equal Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
West Pharmaceutical Governance Vote Puts Leadership Structure And Valuation In Focus - simplywall.st
West Pharmaceutical Services secures top supplier and innovation awards in drug delivery - Traders Union
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
3 Dividend Aristocrats to Buy Now Amid the Middle East Crisis - The Globe and Mail
Are Wall Street analysts bullish on West Pharmaceutical Services stock? - MSN
West Pharmaceutical Services Forms Death Cross, Signals Bearish Trend Ahead - Markets Mojo
How Is West Pharmaceutical's Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
West Pharmaceutical declares dividend, authorizes $1B buyback - MSN
West Pharmaceutical CEO Eric Green to retire in second half 2026 - Investing.com Nigeria
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
John Chevedden Submits Shareholder Proposal to West Pharmaceutical - marketscreener.com
West Pharmaceutical Receives Shareholder Proposal from John Chevedden - marketscreener.com
Swiss National Bank Trims Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Schroder Investment Management Group Acquires 23,474 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Korea Investment CORP Increases Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Compelling Arguments for Including West Pharmaceutical Shares in Your Investment Portfolio Today - Bitget
Reasons to Add West Pharmaceutical Stock to Your Portfolio Right Now - TradingView
Drug Development Services Q4 2025: Revenue Beat, Stock Prices FallNews and Statistics - IndexBox
West Pharmaceutical Services Hits Day Low at $228.40 Amid Price Pressure - Markets Mojo
Winners And Losers Of Q4: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services CEO to retire - Pennsylvania Business Report -
Barclays PLC Sells 59,572 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MSN
West Pharma CEO Eric Green to retire after 11 years at the helm - Reuters
3 Reasons to Sell WST and 1 Stock to Buy Instead - Finviz
West Pharmaceutical Services launches West Synchrony S1 prefillable syringe system - Traders Union
West Pharmaceutical Services Inc (WST) Trading Down 4.48% on Mar 10 - GuruFocus
West Pharmaceutical Services (NYSE:WST) Shares Gap DownShould You Sell? - MarketBeat
West Pharmaceutical (WST) slides as investors digest CEO retirement plan and conference commentary - Quiver Quantitative
West Pharmaceutical at Barclays Conference: Strategic Shifts and Growth Projections - Investing.com
Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat And Upbeat 2026 GLP 1 Guidance - Sahm
West Pharmaceutical (WST) Announces CEO Eric Green's Upcoming Re - GuruFocus
West Pharmaceutical (WST) CEO to Retire, Leadership Transition P - GuruFocus
West Pharmaceutical CEO Eric Green to retire in second half 2026 By Investing.com - Investing.com South Africa
West Pharmaceutical Services (WST) Announces CEO Retirement Plans - GuruFocus
West Pharmaceutical Services, Inc. Announces Eric M. Green Plans to Retire as President and Chair of Board - marketscreener.com
West Pharmaceutical Services, Inc. Announces Eric M. Green Plans to Retire as Chief Executive Officer - marketscreener.com
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
After doubling sales and 350% return, West Pharma chief plans exit - Stock Titan
West Pharmaceutical Services to Present at Two Healthcare Conferences - MyChesCo
LGT Group Foundation Sells 14,341 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Pharmaceutical Packaging Market to Exceed $219B by 2031 as Sustainability & Injectable Drug Packaging Reshape Industry Dynamics, Says Mordor Intelligence - GlobeNewswire Inc.
Blair William & Co. IL Has $16.79 Million Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Female expert achievements celebrated with new blog articles, West Pharmaceutical Services asserts - Traders Union
West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Rating of "Buy" by Analysts - MarketBeat
Neo Ivy Capital Management Makes New Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Aug Closing: Will West Pharmaceutical Services Inc outperform small cap indexesMarket Rally & Scalable Portfolio Growth Ideas - baoquankhu1.vn
West Pharma climbs 0.62% following robust Q4 results and GLP-1 momentum, securing the 501st spot with $260M in trading volume as analysts highlight a 25% price premium - Bitget
WST (West Pharmaceutical Services) GF Value : $354.87 (As of Mar. 13, 2026) - GuruFocus
S&P 500 Stock Analysis: Amazon's Potential vs. Akamai & West Pharma ConcernsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
0.12%
0.97%
大文字化:
|
ボリューム (24 時間):